Table 1.
Clinico-pathological characteristics of patients undergoing either total or subtotal gastrectomy following neoadjuvant treatment
| Number of patients | 243 | |
| Age (years) | 67 (24–81) | |
| Gender | ||
| Male | 171 | |
| Female | 72 | |
| Tumour location | ||
| Distal (STG) | 97 | |
| Proximal (TG) | 146 | |
| cT stage/ypT stage | ||
| cTx/ypT0 | 5 (2%) | 17 (7%) |
| cT1/ypT1 | 4 (2%) | 31 (13%) |
| cT2/ypT2 | 10 (4%) | 78 (32%) |
| cT3/ypT3 | 135 (56%) | 87 (36%) |
| cT4/ypT4 | 89 (37%) | 30 (12%) |
| cNsStage/ypN stage | ||
| cN0/ypN0 | 39 (16%) | 107 (44%) |
| cN1/ypN1 | 140 (58%) | 52 (21%) |
| cN2/ypN2 | 52 (21%) | 37 (15%) |
| cN3/ypN3 | 12 (5%) | 47 (19%) |
| Radicality | ||
| R0 | 235 | |
| R1 | 8 | |
| Median number of resected nodes | 32 (10–142) | |
| Median number of positive nodes | 1 (0–30) | |